Can serum glutathione-s-transferase levels in carcinoma cervix be a predictor of radiation response?

Krishnananda Prabhu, P. Gopalakrishna Bhat, D. M. Vasudevan

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

We conducted a pilot study wherein serum Glutathione-S-transferase levels were measured before and after radiotherapy in carcinoma cervix patients and correlated with response to treatment during a two-year follow-up period. Out of 17 patients who received radiotherapy, 9 showed a significant decrease (p< 0.005) while 8 showed significant increase (p< 0.004) in post radiotherapy glutathione-S-transferase values as compared to pre treatment values respectively. These patients were followed up for two years and we observed that 71% who had significant increase in post radiotherapy values had relapse of cancer within 2 years where as 66% of those who had significant decrease in post radiotherapy values had no evidence of relapse. This shows that alterations in serum Glutathione-S-transferase levels may help us to predict radiation response.

Original languageEnglish
Pages (from-to)95-97
Number of pages3
JournalIndian Journal of Clinical Biochemistry
Volume20
Issue number1
DOIs
Publication statusPublished - 01-01-2005

Fingerprint

Radiotherapy
Transferases
Glutathione Transferase
Cervix Uteri
Glutathione
Radiation
Carcinoma
Serum
Recurrence
Therapeutics
Neoplasms

All Science Journal Classification (ASJC) codes

  • Clinical Biochemistry

Cite this

@article{b8aa346cbfd4405eb575198c4eef0d68,
title = "Can serum glutathione-s-transferase levels in carcinoma cervix be a predictor of radiation response?",
abstract = "We conducted a pilot study wherein serum Glutathione-S-transferase levels were measured before and after radiotherapy in carcinoma cervix patients and correlated with response to treatment during a two-year follow-up period. Out of 17 patients who received radiotherapy, 9 showed a significant decrease (p< 0.005) while 8 showed significant increase (p< 0.004) in post radiotherapy glutathione-S-transferase values as compared to pre treatment values respectively. These patients were followed up for two years and we observed that 71{\%} who had significant increase in post radiotherapy values had relapse of cancer within 2 years where as 66{\%} of those who had significant decrease in post radiotherapy values had no evidence of relapse. This shows that alterations in serum Glutathione-S-transferase levels may help us to predict radiation response.",
author = "Krishnananda Prabhu and Bhat, {P. Gopalakrishna} and Vasudevan, {D. M.}",
year = "2005",
month = "1",
day = "1",
doi = "10.1007/BF02893050",
language = "English",
volume = "20",
pages = "95--97",
journal = "Indian Journal of Clinical Biochemistry",
issn = "0970-1915",
publisher = "Springer India",
number = "1",

}

Can serum glutathione-s-transferase levels in carcinoma cervix be a predictor of radiation response? / Prabhu, Krishnananda; Bhat, P. Gopalakrishna; Vasudevan, D. M.

In: Indian Journal of Clinical Biochemistry, Vol. 20, No. 1, 01.01.2005, p. 95-97.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Can serum glutathione-s-transferase levels in carcinoma cervix be a predictor of radiation response?

AU - Prabhu, Krishnananda

AU - Bhat, P. Gopalakrishna

AU - Vasudevan, D. M.

PY - 2005/1/1

Y1 - 2005/1/1

N2 - We conducted a pilot study wherein serum Glutathione-S-transferase levels were measured before and after radiotherapy in carcinoma cervix patients and correlated with response to treatment during a two-year follow-up period. Out of 17 patients who received radiotherapy, 9 showed a significant decrease (p< 0.005) while 8 showed significant increase (p< 0.004) in post radiotherapy glutathione-S-transferase values as compared to pre treatment values respectively. These patients were followed up for two years and we observed that 71% who had significant increase in post radiotherapy values had relapse of cancer within 2 years where as 66% of those who had significant decrease in post radiotherapy values had no evidence of relapse. This shows that alterations in serum Glutathione-S-transferase levels may help us to predict radiation response.

AB - We conducted a pilot study wherein serum Glutathione-S-transferase levels were measured before and after radiotherapy in carcinoma cervix patients and correlated with response to treatment during a two-year follow-up period. Out of 17 patients who received radiotherapy, 9 showed a significant decrease (p< 0.005) while 8 showed significant increase (p< 0.004) in post radiotherapy glutathione-S-transferase values as compared to pre treatment values respectively. These patients were followed up for two years and we observed that 71% who had significant increase in post radiotherapy values had relapse of cancer within 2 years where as 66% of those who had significant decrease in post radiotherapy values had no evidence of relapse. This shows that alterations in serum Glutathione-S-transferase levels may help us to predict radiation response.

UR - http://www.scopus.com/inward/record.url?scp=14944348787&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14944348787&partnerID=8YFLogxK

U2 - 10.1007/BF02893050

DO - 10.1007/BF02893050

M3 - Article

AN - SCOPUS:14944348787

VL - 20

SP - 95

EP - 97

JO - Indian Journal of Clinical Biochemistry

JF - Indian Journal of Clinical Biochemistry

SN - 0970-1915

IS - 1

ER -